Menu
US
elucidating1920x640
Application Note

AlphaLISA SureFire Ultra: elucidating TREM2/DAP12 signaling in neuroinflammation

Accelerate your research on neuroinflammatory pathways with the advanced AlphaLISA SureFire® Ultra™ platform. This innovative, no-wash assay technology offers exceptional sensitivity for studying key signaling events, including TREM2/DAP12 activation and its role in Alzheimer’s Disease (AD) pathology.

Key Highlights:

  • Analyze critical TREM2/DAP12 signaling components, including phospho and aggregate states.
  • Achieve rapid, reproducible results for post-translational modifications.
  • Ideal for both immortalized cell lines and primary macrophages.

Discover how AlphaLISA SureFire® Ultra™ empowers breakthroughs in neurodegenerative disease research. Download the application note today.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

AlphaLISA SureFire Ultra: elucidating TREM2/DAP12 signaling in neuroinflammation

Download Application Note